TWO SIGMA SECURITIES, LLC

Broker-Dealer

Position in SGMOQ — Sangamo Therapeutics, Inc

CIK 1450144 NEW YORK, NY

Back to SGMOQ Full portfolio

Position in SGMOQ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$15,025

+$7,624 QoQ

Shares Held

60,102

+241.1% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2020

4 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMOQ Over Time

Shares Held

Position Value (USD)

Derivatives in SGMOQ

reported options exposure · as of Dec 31, 2020

CallValue

$223,223

CallShares

14,300

PutValue

$173,271

PutShares

11,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TWO SIGMA SECURITIES, LLC holds $22,488,370 across 103 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	5,761	$3,592,213
2	ALNY	Alnylam Pharmaceuticals, Inc.	5,585	$1,681,252
3	BBIO	BridgeBio Pharma, Inc.	17,689	$1,317,476
4	MDGL	Madrigal Pharmaceuticals, Inc.	2,219	$1,191,492
5	INSM	INSMED Inc	10,338	$1,102,237
6	HALO	Halozyme Therapeutics, Inc.	12,525	$980,331
7	ARWR	Arrowhead Pharmaceuticals, Inc.	11,256	$917,476
8	AXSM	Axsome Therapeutics, Inc.	3,708	$907,607

All Filings in SGMOQ

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$15,025	60,102	+241.1%	Shares	Sole	2026-05-15
2025-12-31	$7,401	17,622	-73.0%	Shares	Sole	2026-02-17
2025-09-30	$43,759	65,312	—	Shares	Sole	2025-11-14
2020-12-31	$223,223	14,300	—	Call	Sole	2021-02-16
2020-12-31	$173,271	11,100	—	Put	Sole	2021-02-16
No filing history on record for this holder in this stock.